+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 40Years +
All Genders
ID07843472

Randomized Study of Weekly Petrelintide Injections Versus Placebo for Weight Management in Adults With Overweight or Obesity and Cardiovascular Disease

Led by Hoffmann-La Roche · Updated on 2026-10-07

2500

Participants Needed

3

Research Sites

10 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of petrelintide compared to a placebo in adults who have overweight or obesity along with established cardiovascular disease. This Phase III study aims to understand how petrelintide, combined with a reduced-calorie diet and increased physical activity, may help manage weight in this population. Participants will receive either petrelintide or a matching placebo, both given as weekly subcutaneous injections using a drug-device combination product. The study follows a randomized, double-blind, placebo-controlled, parallel-group design, with treatment continuing up to 64 weeks. Both groups will also follow a reduced-calorie diet and increase physical activity during the trial. Throughout the study, participants will undergo regular assessments including measurements of body weight, waist circumference, blood tests for cholesterol and glucose levels, as well as questionnaires on quality of life and physical functioning. Researchers will monitor changes from baseline to week 64 and track any adverse events. The total participation duration spans the 64-week treatment period with ongoing monitoring of safety and effectiveness measures.

CONDITIONS

Brief Title

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease

Research Team

R

Reference Study ID Number: CC46446 https://forpatients.roche.com/No attachments to email below.

F

Fastest Response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here